Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (201-210 of 473) with videos related to

Pageof 48
Sort By:
Antimicrobial Agents and Chemotherapy|January 7, 2015
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United StatesRodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Journal of Clinical Microbiology|September 28, 2018
Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus IsolatesHelio S Sader, Paul R Rhomberg, Timothy B Doyle, et al.
Revista Gaucha De Enfermagem|January 1, 1995
[Teaching neonatal nursing: experiences of teachers and students]V R Da Poian, R M Vianna, I Agostini, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 28, 2009
Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolatesRodrigo E Mendes, Ronald N Jones, Lalitagauri M Deshpande, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|October 14, 2003
Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000)Rodrigo E Mendes, Adriana O Reis, Ana C Gales, et al.
Journal of Chemotherapy (Florence, Italy)|May 17, 2011
Eight-year (2002-2009) summary of the linezolid (Zyvox® Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countriesJ E Ross, D J Farrell, R E Mendes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infectionsCesar A Arias, Rodrigo E Mendes, Matthew G Stilwell, et al.
The Pediatric Infectious Disease Journal|September 16, 2014
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012)Helio S Sader, Rodrigo E Mendes, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2017
<i>In Vitro</i> Activities of Ceftaroline and Comparators against Streptococcus pneumoniae Isolates from U.S. Hospitals: Results from Seven Years of the AWARE Surveillance Program (2010 to 2016)Michael A Pfaller, Rodrigo E Mendes, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
<i>In Vitro</i> Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of <i>Enterobacteriaceae</i>, Including Molecularly Characterized StrainsRodrigo E Mendes, Paul R Rhomberg, Troy Lister, et al.
Pageof 48

Showing results (201-210 of 473) with videos related to

Sort By:
Pageof 48
Antimicrobial Agents and Chemotherapy|January 7, 2015
Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United StatesRodrigo E Mendes, Helio S Sader, Robert K Flamm, et al.
Journal of Clinical Microbiology|September 28, 2018
Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus IsolatesHelio S Sader, Paul R Rhomberg, Timothy B Doyle, et al.
Revista Gaucha De Enfermagem|January 1, 1995
[Teaching neonatal nursing: experiences of teachers and students]V R Da Poian, R M Vianna, I Agostini, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 28, 2009
Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolatesRodrigo E Mendes, Ronald N Jones, Lalitagauri M Deshpande, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|October 14, 2003
Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000)Rodrigo E Mendes, Adriana O Reis, Ana C Gales, et al.
Journal of Chemotherapy (Florence, Italy)|May 17, 2011
Eight-year (2002-2009) summary of the linezolid (Zyvox® Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countriesJ E Ross, D J Farrell, R E Mendes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infectionsCesar A Arias, Rodrigo E Mendes, Matthew G Stilwell, et al.
The Pediatric Infectious Disease Journal|September 16, 2014
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012)Helio S Sader, Rodrigo E Mendes, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2017
<i>In Vitro</i> Activities of Ceftaroline and Comparators against Streptococcus pneumoniae Isolates from U.S. Hospitals: Results from Seven Years of the AWARE Surveillance Program (2010 to 2016)Michael A Pfaller, Rodrigo E Mendes, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
<i>In Vitro</i> Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of <i>Enterobacteriaceae</i>, Including Molecularly Characterized StrainsRodrigo E Mendes, Paul R Rhomberg, Troy Lister, et al.
Pageof 48